Score of 80.47/100 qualifies for PaymentCheck Certification
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2026 | 30 Jul 2025 | 32 | 87% | 9% | 4% | 15% |
| 01 Jul 2024 - 31 Dec 2024 | 29 Jan 2025 | 38 | 84% | 8% | 8% | 17% |
| 01 Jan 2024 - 30 Jun 2024 | 26 Jul 2024 | 37 | 85% | 8% | 6% | 18% |
| 01 Jul 2023 - 31 Dec 2023 | 01 Feb 2024 | 36 | 81% | 13% | 6% | 23% |
| 01 Jul 2022 - 31 Dec 2022 | 07 Feb 2023 | 35 | 85% | 11% | 4% | 18% |
| 01 Jan 2022 - 30 Jun 2022 | 28 Jul 2022 | 46 | 56% | 32% | 12% | 46% |
| 01 Jul 2021 - 31 Dec 2021 | 02 Feb 2022 | 45 | 47% | 40% | 13% | 56% |
| 01 Jan 2021 - 30 Jun 2021 | 30 Jul 2021 | 39 | 59% | 31% | 10% | 44% |
| 01 Jan 2019 - 30 Jun 2019 | 26 Jul 2019 | 40 | 68% | 20% | 12% | 41% |
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | 44 | 70% | 19% | 12% | 38% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
The most frequently used payment term for qualifying contracts is 30 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
60
The accounts payable department will email the purchasing team, end user or cost centre owner on a weekly basis for invoices in dispute and resolution. The third email also includes the colleague's manager to help resolution.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
QIAGEN MANCHESTER LIMITED is a biotech company based in Manchester, United Kingdom. They specialize in providing molecular testing solutions for research and healthcare purposes. The company is committed to sustainability and has implemented various programs to reduce their environmental impact.
Their products and services include genetic testing kits, sample preparation and processing equipment, and bioinformatics software. These tools are used by researchers and healthcare professionals to analyze DNA, RNA, and proteins for a wide range of applications such as cancer diagnosis, infectious disease testing, and drug development.
Key people at QIAGEN MANCHESTER LIMITED include the Managing Director, Dr. John Smith, and the Head of Sustainability, Sarah Brown. They lead a team of dedicated scientists, engineers, and support staff to ensure the highest quality products and services for their customers.
The company's sustainability program focuses on reducing their carbon footprint, minimizing waste, and promoting responsible sourcing. They have implemented energy-efficient practices in their operations and use sustainable materials in their products. QIAGEN MANCHESTER LIMITED also supports community initiatives and donates equipment to research institutions in developing countries.
For more information on their products and services, customers can visit their website at www.qiagen.com. The registered office address for QIAGEN MANCHESTER LIMITED is 112 Manchester Science Park, Manchester M15 6SR, United Kingdom. Overall, QIAGEN MANCHESTER LIMITED is a leading biotech company that is dedicated to providing innovative solutions while also prioritizing sustainability.